Alembic Pharmaceuticals to set up JV with Orbicular

To develop and commercialise dermatology products

Alembic Pharmaceuticals (APL) has entered into joint venture agreement dated 20 April 2016 with Orbicular Pharmaceutical Technologies (Orbicular) and Dr M S Mohan to develop, manufacture and commercialise dermatology products for worldwide markets.

Orbicular has capabilities in developing dermatology products with a fully equipped and staffed research laboratory in Hyderabad and has a pipeline of products at various stages of development. Manufacturing facility will be established in Aleor Dermaceuticals to enable worldwide registrations.

APL and Orbicular will own 60% and 40% of the equity capital of Aleor when the transaction is completed.

Powered by Capital Market - Live News